These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 536267)

  • 21. Tumour response endpoints in the BA1112 rat sarcoma.
    Martin DF; Moulder JE; Fischer JJ
    Br J Cancer Suppl; 1980 Apr; 4():271-4. PubMed ID: 6932936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of vinblastine in rat blood plasma and tumour tissue determined by a biological method using flow cytofluorimetry.
    Kipp JB; Barendsen GW
    Eur J Cancer Clin Oncol; 1981 Aug; 17(8):867-73. PubMed ID: 7198977
    [No Abstract]   [Full Text] [Related]  

  • 23. The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas.
    Sagowski C; Tesche S; Zywietz F; Wenzel S; Metternich FU
    Onkologie; 2004 Feb; 27(1):54-7. PubMed ID: 15007249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined treatment of rat rhabdomyosarcoma R1H with mitomycin C and X-rays.
    Baisch H; von Stritzky B
    Strahlenther Onkol; 1990 Jun; 166(6):430-4. PubMed ID: 2114041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF; Sladek NE
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined nitrogen mustard--radiation studies with a mouse tumor.
    Hill RP
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1611-6. PubMed ID: 536269
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune-deprived mice.
    Houghton JA; Houghton PJ; Brodeur GM; Green AA
    Int J Cancer; 1981 Oct; 28(4):409-15. PubMed ID: 7309287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of tumor growth by the peptidoglycan from Bacillus megaterium.
    Nauciel C; Goguel AF
    J Natl Cancer Inst; 1977 Dec; 59(6):1723-6. PubMed ID: 411939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host cell cytotoxicity, cellular repopulation dynamics, and phase-specific cell survival in X-irradiated rat rhabdomyosarcoma tumors.
    Tenforde TS; Kavanau KS; Afzal SM; Curtis SB
    Radiat Res; 1990 Jul; 123(1):32-43. PubMed ID: 2371379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Skin reaction to vinblastine.
    Lampkin BC
    Lancet; 1969 Apr; 1(7600):891. PubMed ID: 4180557
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and biological responses after treatment of the rat R-1 rhabdomyosarcoma with methotrexate.
    Kipp JB; Leyva A; van Gennip AH; Kal HB
    Int J Cancer; 1993 Jul; 54(6):945-51. PubMed ID: 7687589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of desacetyl vinblastine amide (DVA) against human sarcomas heterotransplanted in nude mice.
    Sordillo PP; Hajdu SI; Magill GB; Lesser M; Helson L
    Cancer Clin Trials; 1980; 3(4):391-4. PubMed ID: 7428143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
    Focan C; Barbason H; Betz EH
    Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinca alkaloids. Experimental and clinical trials.
    Klener P
    Acta Univ Carol Med Monogr; 1974; (58):1-157. PubMed ID: 4374079
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapeutic "fingerprints" of two experimental tumors in vitro.
    Morasca L; Balconi G; De Nadai F; Dolfini E
    Eur J Cancer (1965); 1972 Aug; 8(4):429-35. PubMed ID: 5073305
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of microwave heating on the radiation response of the rhabdomyosarcoma.
    Zywietz F
    Strahlentherapie; 1982 Apr; 158(4):255-7. PubMed ID: 7101339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.
    Landuyt W; Ahmed B; Nuyts S; Theys J; Op de Beeck M; Rijnders A; Anné J; van Oosterom A; van den Bogaert W; Lambin P
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):443-50. PubMed ID: 11173139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modification of selected leukocyte functions in albino rats caused by the transplantable Jensen sarcoma and by therapeutic trials of cyclophosphamide and vinblastine, Clostridium butyricum M55 and short-term hyperglycemia].
    Hambsch K; Henke R; Ludewig R
    Arch Geschwulstforsch; 1984; 54(5):369-76. PubMed ID: 6497582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced tumor cure rates by combination of heat and irradiation with a one day interval. An experimental study.
    van den Boogaard L
    Eur J Cancer (1965); 1980 Jan; 16(1):93-7. PubMed ID: 7358082
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sodium selenite reduces acute radiogenic damage of the rat parotid glands during fractionated irradiation].
    Sagowski C; Wenzel S; Tesche S; Jenicke L; Kehrl W; Roeser K; Metternich FU
    HNO; 2004 Dec; 52(12):1067-75. PubMed ID: 15597168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.